Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
siplizumab t-cell surface antigen cd2 biotech Clinical trial target TTD , drugbank , DGIDB Transplanted tissue[MeSHID:D019737]
Disease[MeSHID:D004194]
Graft-vs-Host Disease[MeSHID:D006086]
Lymphoma[MeSHID:D008223]
leukemia[MeSHID:D007938]
Psoriasis[MeSHID:D011565]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 63.65 investigational,phase 2 inhibitor
siplizumab t-cell surface antigen cd2 biotech Clinical trial target TTD , drugbank , DGIDB Transplanted tissue[MeSHID:D019737]
Disease[MeSHID:D004194]
Graft-vs-Host Disease[MeSHID:D006086]
Lymphoma[MeSHID:D008223]
leukemia[MeSHID:D007938]
Psoriasis[MeSHID:D011565]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 63.65 investigational,phase 2 unknown
click here to return to the previous page